Bloomios

Bloomios Debt Growth

The Year-over-Year Debt Growth of Bloomios (BLMS) as of Oct 26, 2026 is 776.55 %. In the previous year, Year-over-Year Debt Growth was 36.96 % — a change of 2,000.83% (higher).

Debt Growth

776.55 %

YoY

2,000.83%

Last updated:

Year-over-Year Debt Growth of Bloomios is 2022 776.55 % . Year-over-Year Debt Growth of Bloomios was 2021 36.96 % . It decreases by 2,000.83% higher compared to the previous year.

The Bloomios Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2020
4,488.53 USD
Jan 1, 2021
36.96 USD
Jan 1, 2022
776.55 USD
The Bloomios Debt Growth history
YEARDebt GrowthYoY
776.55 %+2,000.83%
36.96 %-99.18%
4,488.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Year-over-Year Debt Growth of Bloomios is 776.55 % in 2022.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Bloomios since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Bloomios historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Bloomios

All Key Metrics — Bloomios